HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

2008 Budget Should Cover Research On Nanotech Risk – Congressmen

This article was originally published in The Rose Sheet

Executive Summary

The Bush Administration should place a high priority on developing and funding a risk-focused nanotechnology research plan in the fiscal 2008 budget, according to Reps. Sherwood Boehlert (R-N.Y.) and Bart Gordon (D-Tenn.)

You may also be interested in...



Nanotechnology Benefits/Risks Presented To FDA Nanotech Task Force

Governments, businesses and academia should take a balanced approach in developing a policy framework for nanotechnology to reap its economic and societal benefits, according to Matthew Jaffe of the Washington, D.C. law firm Crowell & Moring

Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”

Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement

Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”

Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014350

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel